AstraZeneca - 26 Year Stock Price History | AZN

Historical daily share price chart and data for AstraZeneca since 1993 adjusted for splits. The latest closing stock price for AstraZeneca as of December 09, 2019 is 47.77.
  • The all-time high AstraZeneca stock closing price was 49.03 on October 31, 2019.
  • The AstraZeneca 52-week high stock price is 49.22, which is 3% above the current share price.
  • The AstraZeneca 52-week low stock price is 35.30, which is 26.1% below the current share price.
  • The average AstraZeneca stock price for the last 52 weeks is 41.66.
AstraZeneca Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 41.8603 37.8000 49.0300 35.4900 47.7700 25.78%
2018 36.8811 35.3800 41.4900 32.9700 37.9800 9.45%
2017 31.7763 27.7100 35.3600 26.7200 34.7000 27.01%
2016 30.0459 33.4000 34.5000 25.8100 27.3200 -19.53%
2015 33.6474 35.2000 36.6750 30.2800 33.9500 -3.52%
2014 35.2402 29.2850 40.5450 29.2550 35.1900 18.54%
2013 25.3860 24.1200 29.7500 22.3350 29.6850 25.60%
2012 22.8754 23.8600 24.4500 20.0150 23.6350 2.12%
2011 23.8014 23.1800 26.2000 20.4750 23.1450 0.22%
2010 23.7197 23.7050 26.7500 20.4550 23.0950 -1.60%
2009 20.8024 20.2950 23.7700 15.1200 23.4700 14.40%
2008 21.0898 21.2150 24.9250 17.0500 20.5150 -4.18%
2007 25.9364 26.9450 29.5200 21.4100 21.4100 -20.04%
2006 27.9060 25.1500 33.1850 22.5600 26.7750 10.19%
2005 21.6932 18.1100 24.7500 17.3600 24.3000 33.55%
2004 22.4752 24.5000 25.4250 17.9400 18.1950 -24.78%
2003 20.2282 17.4400 24.7350 14.9900 24.1900 37.87%
2002 20.4272 22.9150 26.0000 14.5750 17.5450 -24.70%
2001 23.4955 25.4400 25.5550 21.3000 23.3000 -9.51%
2000 22.0648 20.5650 26.5000 15.7500 25.7500 23.35%
1999 20.9555 22.8450 24.2500 17.6900 20.8750 -6.97%
1998 20.3917 18.1667 24.5000 16.1250 22.4400 24.67%
1997 15.5931 13.6867 18.9167 13.4783 18.0000 28.57%
1996 11.4007 9.8750 14.2500 9.5000 14.0000 43.91%
1995 8.2628 6.8333 10.3333 6.7083 9.7283 41.95%
1994 6.0011 6.1667 7.0217 5.0833 6.8533 10.39%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $125.101B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $369.462B 16.01
Roche Holding AG (RHHBY) Switzerland $264.146B 0.00
Merck (MRK) United States $226.211B 17.52
Pfizer (PFE) United States $211.902B 12.60
Novartis AG (NVS) Switzerland $211.006B 17.81
Novo Nordisk (NVO) Denmark $134.360B 23.16
AbbVie (ABBV) United States $128.628B 10.08
Sanofi (SNY) France $115.265B 14.16
Eli Lilly (LLY) United States $114.870B 21.21
GlaxoSmithKline (GSK) United Kingdom $113.512B 13.75
Bristol-Myers Squibb (BMY) United States $97.676B 13.66
Bayer (BAYRY) Germany $71.322B 10.56
H Lundbeck (HLUYY) Denmark $7.591B 10.95